CONSOLIDATED BALANCE SHEETS (AUDITED) - USD ($)	Dec. 31, 2025	Dec. 31, 2024
Current assets
Cash	$ 2,620	$ 10,336
Accounts receivable	5,000	5,000
Due from related party	17,592	17,592
Prepaid expense and other current assets	2,319	9,100
Total current assets	27,531	42,028
Patents and trademarks, net	100,036	116,189
Total assets	127,567	158,217
Current liabilities
Accounts payable and accrued liabilities	1,253,669	858,993
Accrued interest payable	3,357,157	2,784,909
Due to related party	45,044	13,364
Loans payable	10,000
Convertible notes payable	352,075
Total current liabilities	5,017,945	3,657,266
Convertible notes payable related party	5,372,403	5,372,403
Convertible notes payable		352,075
Total liabilities	10,390,348	9,381,744
Stockholders' deficit
Common stock; $0.001 par value; 200,000,000 shares authorized; 5,403,843 and 5,316,843 shares issued and outstanding at December 31, 2025 and 2024, respectively	5,404	5,317
Shares payable		10,000
Additional paid-in capital	30,741,991	30,707,298
Accumulated deficit	(41,010,176)	(39,946,142)
Total stockholders' deficit	(10,262,781)	(9,223,527)
Total liabilities and stockholders' deficit	$ 127,567	$ 158,217

No definition available.

Name:	SKVI_ConvertibleNotesPayable1
Namespace Prefix:	SKVI_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.